Wall Street Associates’s DexCom DXCM Stock Holding History

Wall Street Associates’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-66,660	Closed	-$1.36M	–	233
2015 Q4	$1.36M	Sell	66,660 -1,600	-2%	-$33.3K	0.38%	88
2015 Q3	$1.47M	Sell	68,260 -34,988	-34%	-$781K	0.28%	107
2015 Q2	$2.06M	Buy	103,248 +26,384	+34%	+$463K	0.19%	131
2015 Q1	$1.2M	Buy	+76,864	New	+$1.16M	0.11%	194

Other funds holding DXCM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

CCI

Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Wall Street Associates's DXCM Position: Q1 2016 in Review

Wall Street Associates sold out of DexCom (DXCM) in Q1 2016, closing a stake of 66,660 shares — an estimated $1.36M sold.

Wall Street Associates first reported a position in DXCM in Q1 2015 and held it in 4 quarters. The position peaked at $2.06M in Q2 2015. 264 funds tracked by Wall St. Rank hold DXCM as of Q1 2016.

Wall Street Associates reported no remaining DexCom position as of Q1 2016 after selling out during the quarter.
Wall Street Associates sold 66,660 DexCom shares in Q1 2016, an estimated $1.36M.
Wall Street Associates first reported a position in DexCom in Q1 2015 and held it in 4 quarters.
Wall Street Associates's DexCom position peaked at $2.06M in Q2 2015.
264 funds tracked by Wall St. Rank held DexCom as of Q1 2016.

Based on Wall Street Associates's 13F filing for Q1 2016, filed 13 May 2016.